From: Modulation of cancer signalling pathway(s) in two -stage mouse skin tumorigenesis by annonacin
Parameter/ Groups | No. of animals | Body weight (g) | Ratio to final body weight | Tumor latency (week) | Tumor incidence (%) | Tumor burden | Tumor volume (mm3) | Tumor regression | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Initial | Effective | Initial | Final | Liver | Kidney | ||||||
I (vehicle control) | 10 | 10 | 23.8 ± 0.6a | 31.7 ± 1.3a | 0.05a | 0.01a | – | – | – | – | – |
II (carcinogen control) | 10 | 10 | 24.0 ± 0.6a | 32.4 ± 0.7ab | 0.07b | 0.02a | 7a | 100a | 2.2 ± 0.4a | 7.9 ± 1.7a | 0.61 ± 0.3a |
III (treatment, annonacin) | 10 | 10 | 22.6 ± 0.5a | 29.6 ± 1.2a | 0.05a | 0.01a | 9b | 50b | 1.6 ± 0.3a | 1.7 ± 0.4b | 0.96 ± 0.4a |
IV (treatment control) | 10 | 10 | 23.6 ± 0.6a | 35.3 ± 1.0b | 0.05a | 0.01a | – | – | – | – | – |
V (reference, curcumin) | 10 | 10 | 23.4 ± 0.7a | 31.7 ± 1.4a | 0.05a | 0.01a | 8ab | 70ab | 1.8 ± 0.3a | 1.9 ± 0.4b | 1.3 ± 0.4a |